(Q37088148)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18283711%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

review article

1 reference

title

Extranodal NK/T-cell lymphoma: diagnosis and treatment cues (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18283711%20AND%20SRC:MED&resulttype=core&format=json

extranodal NK/T-cell lymphoma, nasal type

3 January 2020

main subject

diagnosis

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18283711%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Kengo Takeuchi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18283711%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Koichi Ohshima

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18283711%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Shigeo Nakamura

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18283711%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

language of work or name

1 reference

1 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18283711%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

published in

Hematological Oncology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18283711%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18283711%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18283711%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

66-72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18283711%20AND%20SRC:MED&resulttype=core&format=json

Leukemia and lymphoma of natural killer lineage cells

3 January 2020

cites work

1 reference

7 January 2021

The world health organization classification of malignant lymphomas in japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists

1 reference

7 January 2021

Chromosomal abnormalities of 200 Chinese patients with non-Hodgkin's lymphoma in Taiwan: with special reference to T-cell lymphoma

1 reference

7 January 2021

Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years

1 reference

7 January 2021

Characteristics and uses of natural killer cells

1 reference

7 January 2021

Identification of a common T/natural killer cell progenitor in human fetal thymus.

1 reference

7 January 2021

Nasal T-cell lymphoma as a type of so-called "lethal midline granuloma"

1 reference

7 January 2021

Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms

1 reference

7 January 2021

Expression of natural killer cell markers in non-Hodgkin's lymphomas

1 reference

7 January 2021

Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0.

1 reference

7 January 2021

Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.

1 reference

7 January 2021

Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement

1 reference

7 January 2021

Clinical and biologic features of CD4+CD56+ malignancies

1 reference

7 January 2021

'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes

1 reference

7 January 2021

Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells

1 reference

7 January 2021

Treatment outcome and prognostic factors for primary nasal lymphoma

1 reference

7 January 2021

Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese

1 reference

7 January 2021

CD56+ NK lymphomas: clinicopathological features and prognosis

1 reference

7 January 2021

Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients

1 reference

7 January 2021

Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans

1 reference

7 January 2021

Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma

1 reference

7 January 2021

Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index

1 reference

7 January 2021

Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan

1 reference

7 January 2021

Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type

1 reference

7 January 2021

Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study

1 reference

7 January 2021

Nasal T/NK cell lymphomas commonly express perforin and Fas ligand: important mediators of tissue damage

1 reference

7 January 2021

Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology

1 reference

7 January 2021

Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon

1 reference

7 January 2021

Effect of positive bone marrow EBV in situ hybridization in staging and survival of localized extranodal natural killer/T-cell lymphoma, nasal-type

1 reference

7 January 2021

Discordant CD3 expression in lymphomas when studied on frozen and paraffin sections

1 reference

7 January 2021

Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis.

1 reference

7 January 2021

Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma

1 reference

7 January 2021

CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma?

1 reference

7 January 2021

Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells.

1 reference

7 January 2021

Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment

1 reference

7 January 2021

Extranodal natural killer/T-cell lymphoma, nasal type: the significance of radiotherapeutic parameters

1 reference

7 January 2021

Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx.

1 reference

7 January 2021

Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma

1 reference

7 January 2021

Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy

1 reference

7 January 2021

L-asparaginase induced durable remission of relapsed nasal NK/T-cell lymphoma after autologous peripheral blood stem cell transplantation

1 reference

7 January 2021

L-Asparaginase-Based Induction Therapy for Advanced Extranodal NK/T-Cell Lymphoma

1 reference

7 January 2021

Successful treatment with Erwinia L-asparaginase for recurrent natural killer/T cell lymphoma

1 reference

7 January 2021

The best way to use asparaginase in childhood acute lymphatic leukaemia--still to be defined?

1 reference

7 January 2021

Treatment of acute lymphoblastic leukemia

1 reference

7 January 2021

L-asparaginase-based regimen in the treatment of refractory midline nasal/nasal-type T/NK-cell lymphoma

1 reference

7 January 2021

Autologous stem cell transplantation for nasal NK/T-cell lymphoma: a progress report on its value

1 reference

7 January 2021

Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms.

1 reference

7 January 2021

High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: a retrospective comparison with non-transplantation cases

1 reference

7 January 2021

Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms

1 reference

7 January 2021

Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma

1 reference

7 January 2021

Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract.

1 reference

7 January 2021

Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients

1 reference

7 January 2021

Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen.

1 reference

7 January 2021